ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insulin Glargine Market Insights, Forecast to 2030
Published Date: July 2024
|
Report Code: QYRE-Auto-2316
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Insulin Glargine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Insulin Glargine Market Insights, Forecast to 2030

Code: QYRE-Auto-2316
Report
July 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Aventis
Ganlee
Biocon Ltd.

Insulin Glargine Market Size

The global Insulin Glargine market is projected to grow from US$ 6999.1 million in 2024 to US$ 8856.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period.

Insulin Glargine Market

Insulin Glargine Market

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
Global Insulin Glargine key players include Sanofi-Aventis, Ganlee, etc. Global top two manufacturers hold a share nearly 50%.
USA is the largest market, with a share over 60%, followed by China, and Europe, both have a share about 35 percent.
In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%. And in terms of application, the largest application is Treat type2 diabetes, followed by Treat type1 diabetes.
Report Covers:
This report presents an overview of global market for Insulin Glargine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Insulin Glargine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Insulin Glargine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Insulin Glargine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Insulin Glargine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Insulin Glargine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Insulin Glargine Market Report

Report Metric Details
Report Name Insulin Glargine Market
Accounted market size in 2024 US$ 6999.1 million
Forecasted market size in 2030 US$ 8856.1 million
CAGR 4.0
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Single Dose Vial
  • Pre-filled Syringe
Segment by Application
  • Treat Type2 Diabetes
  • Treat Type1 Diabetes
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biocon
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Insulin Glargine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Insulin Glargine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin Glargine sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Insulin Glargine Market growing?

Ans: The Insulin Glargine Market witnessing a CAGR of 4.0 during the forecast period 2024-2030.

What is the Insulin Glargine Market size in 2030?

Ans: The Insulin Glargine Market size in 2030 will be US$ 8856.1 million.

What is the market share of major companies in Insulin Glargine Market?

Ans: Global top two manufacturers hold a share nearly 50%.

What is the Insulin Glargine Market share by type?

Ans: In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%.

Who are the main players in the Insulin Glargine Market report?

Ans: The main players in the Insulin Glargine Market are Biocon

What are the Application segmentation covered in the Insulin Glargine Market report?

Ans: The Applications covered in the Insulin Glargine Market report are Treat Type2 Diabetes, Treat Type1 Diabetes

What are the Type segmentation covered in the Insulin Glargine Market report?

Ans: The Types covered in the Insulin Glargine Market report are Single Dose Vial, Pre-filled Syringe

1 Study Coverage
1.1 Insulin Glargine Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Glargine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Market by Application
1.3.1 Global Insulin Glargine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Treat Type2 Diabetes
1.3.3 Treat Type1 Diabetes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Insulin Glargine Sales Estimates and Forecasts 2019-2030
2.2 Global Insulin Glargine Revenue by Region
2.2.1 Global Insulin Glargine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Insulin Glargine Revenue by Region (2019-2024)
2.2.3 Global Insulin Glargine Revenue by Region (2025-2030)
2.2.4 Global Insulin Glargine Revenue Market Share by Region (2019-2030)
2.3 Global Insulin Glargine Sales Estimates and Forecasts 2019-2030
2.4 Global Insulin Glargine Sales by Region
2.4.1 Global Insulin Glargine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Insulin Glargine Sales by Region (2019-2024)
2.4.3 Global Insulin Glargine Sales by Region (2025-2030)
2.4.4 Global Insulin Glargine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Insulin Glargine Sales by Manufacturers
3.1.1 Global Insulin Glargine Sales by Manufacturers (2019-2024)
3.1.2 Global Insulin Glargine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Glargine in 2023
3.2 Global Insulin Glargine Revenue by Manufacturers
3.2.1 Global Insulin Glargine Revenue by Manufacturers (2019-2024)
3.2.2 Global Insulin Glargine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Glargine Revenue in 2023
3.3 Global Key Players of Insulin Glargine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Insulin Glargine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Insulin Glargine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Insulin Glargine, Product Offered and Application
3.8 Global Key Manufacturers of Insulin Glargine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Insulin Glargine Sales by Type
4.1.1 Global Insulin Glargine Historical Sales by Type (2019-2024)
4.1.2 Global Insulin Glargine Forecasted Sales by Type (2025-2030)
4.1.3 Global Insulin Glargine Sales Market Share by Type (2019-2030)
4.2 Global Insulin Glargine Revenue by Type
4.2.1 Global Insulin Glargine Historical Revenue by Type (2019-2024)
4.2.2 Global Insulin Glargine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Insulin Glargine Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Glargine Price by Type
4.3.1 Global Insulin Glargine Price by Type (2019-2024)
4.3.2 Global Insulin Glargine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Insulin Glargine Sales by Application
5.1.1 Global Insulin Glargine Historical Sales by Application (2019-2024)
5.1.2 Global Insulin Glargine Forecasted Sales by Application (2025-2030)
5.1.3 Global Insulin Glargine Sales Market Share by Application (2019-2030)
5.2 Global Insulin Glargine Revenue by Application
5.2.1 Global Insulin Glargine Historical Revenue by Application (2019-2024)
5.2.2 Global Insulin Glargine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Insulin Glargine Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Glargine Price by Application
5.3.1 Global Insulin Glargine Price by Application (2019-2024)
5.3.2 Global Insulin Glargine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Insulin Glargine Market Size by Type
6.1.1 US & Canada Insulin Glargine Sales by Type (2019-2030)
6.1.2 US & Canada Insulin Glargine Revenue by Type (2019-2030)
6.2 US & Canada Insulin Glargine Market Size by Application
6.2.1 US & Canada Insulin Glargine Sales by Application (2019-2030)
6.2.2 US & Canada Insulin Glargine Revenue by Application (2019-2030)
6.3 US & Canada Insulin Glargine Market Size by Country
6.3.1 US & Canada Insulin Glargine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Insulin Glargine Sales by Country (2019-2030)
6.3.3 US & Canada Insulin Glargine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Insulin Glargine Market Size by Type
7.1.1 Europe Insulin Glargine Sales by Type (2019-2030)
7.1.2 Europe Insulin Glargine Revenue by Type (2019-2030)
7.2 Europe Insulin Glargine Market Size by Application
7.2.1 Europe Insulin Glargine Sales by Application (2019-2030)
7.2.2 Europe Insulin Glargine Revenue by Application (2019-2030)
7.3 Europe Insulin Glargine Market Size by Country
7.3.1 Europe Insulin Glargine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Insulin Glargine Sales by Country (2019-2030)
7.3.3 Europe Insulin Glargine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Insulin Glargine Market Size
8.1.1 China Insulin Glargine Sales (2019-2030)
8.1.2 China Insulin Glargine Revenue (2019-2030)
8.2 China Insulin Glargine Market Size by Application
8.2.1 China Insulin Glargine Sales by Application (2019-2030)
8.2.2 China Insulin Glargine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Insulin Glargine Market Size by Type
9.1.1 Asia Insulin Glargine Sales by Type (2019-2030)
9.1.2 Asia Insulin Glargine Revenue by Type (2019-2030)
9.2 Asia Insulin Glargine Market Size by Application
9.2.1 Asia Insulin Glargine Sales by Application (2019-2030)
9.2.2 Asia Insulin Glargine Revenue by Application (2019-2030)
9.3 Asia Insulin Glargine Sales by Region
9.3.1 Asia Insulin Glargine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Insulin Glargine Revenue by Region (2019-2030)
9.3.3 Asia Insulin Glargine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Insulin Glargine Market Size by Type
10.1.1 Middle East, Africa and Latin America Insulin Glargine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Insulin Glargine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Insulin Glargine Market Size by Application
10.2.1 Middle East, Africa and Latin America Insulin Glargine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Insulin Glargine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Insulin Glargine Sales by Country
10.3.1 Middle East, Africa and Latin America Insulin Glargine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Insulin Glargine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Insulin Glargine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Company Information
11.1.2 Sanofi-Aventis Overview
11.1.3 Sanofi-Aventis Insulin Glargine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Sanofi-Aventis Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi-Aventis Recent Developments
11.2 Ganlee
11.2.1 Ganlee Company Information
11.2.2 Ganlee Overview
11.2.3 Ganlee Insulin Glargine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Ganlee Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ganlee Recent Developments
11.3 Biocon
11.3.1 Biocon Company Information
11.3.2 Biocon Overview
11.3.3 Biocon Insulin Glargine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Biocon Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biocon Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Insulin Glargine Industry Chain Analysis
12.2 Insulin Glargine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Glargine Production Mode & Process
12.4 Insulin Glargine Sales and Marketing
12.4.1 Insulin Glargine Sales Channels
12.4.2 Insulin Glargine Distributors
12.5 Insulin Glargine Customers
13 Market Dynamics
13.1 Insulin Glargine Industry Trends
13.2 Insulin Glargine Market Drivers
13.3 Insulin Glargine Market Challenges
13.4 Insulin Glargine Market Restraints
14 Key Findings in The Global Insulin Glargine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Sanofi Aventis
Ganlee
Biocon Ltd.
List of Tables
    Table 1. Global Insulin Glargine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Single Dose Vial
    Table 3. Major Manufacturers of Pre-filled Syringe
    Table 4. Global Insulin Glargine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Insulin Glargine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Insulin Glargine Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Insulin Glargine Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Insulin Glargine Revenue Market Share by Region (2019-2024)
    Table 9. Global Insulin Glargine Revenue Market Share by Region (2025-2030)
    Table 10. Global Insulin Glargine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Insulin Glargine Sales by Region (2019-2024) & (M mL)
    Table 12. Global Insulin Glargine Sales by Region (2025-2030) & (M mL)
    Table 13. Global Insulin Glargine Sales Market Share by Region (2019-2024)
    Table 14. Global Insulin Glargine Sales Market Share by Region (2025-2030)
    Table 15. Global Insulin Glargine Sales by Manufacturers (2019-2024) & (M mL)
    Table 16. Global Insulin Glargine Sales Share by Manufacturers (2019-2024)
    Table 17. Global Insulin Glargine Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Insulin Glargine Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Insulin Glargine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Insulin Glargine Price by Manufacturers 2019-2024 (USD/mL)
    Table 21. Global Insulin Glargine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Insulin Glargine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Glargine as of 2023)
    Table 23. Global Key Manufacturers of Insulin Glargine, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Insulin Glargine, Product Offered and Application
    Table 25. Global Key Manufacturers of Insulin Glargine, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Insulin Glargine Sales by Type (2019-2024) & (M mL)
    Table 28. Global Insulin Glargine Sales by Type (2025-2030) & (M mL)
    Table 29. Global Insulin Glargine Sales Share by Type (2019-2024)
    Table 30. Global Insulin Glargine Sales Share by Type (2025-2030)
    Table 31. Global Insulin Glargine Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Insulin Glargine Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Insulin Glargine Revenue Share by Type (2019-2024)
    Table 34. Global Insulin Glargine Revenue Share by Type (2025-2030)
    Table 35. Insulin Glargine Price by Type (2019-2024) & (USD/mL)
    Table 36. Global Insulin Glargine Price Forecast by Type (2025-2030) & (USD/mL)
    Table 37. Global Insulin Glargine Sales by Application (2019-2024) & (M mL)
    Table 38. Global Insulin Glargine Sales by Application (2025-2030) & (M mL)
    Table 39. Global Insulin Glargine Sales Share by Application (2019-2024)
    Table 40. Global Insulin Glargine Sales Share by Application (2025-2030)
    Table 41. Global Insulin Glargine Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Insulin Glargine Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Insulin Glargine Revenue Share by Application (2019-2024)
    Table 44. Global Insulin Glargine Revenue Share by Application (2025-2030)
    Table 45. Insulin Glargine Price by Application (2019-2024) & (USD/mL)
    Table 46. Global Insulin Glargine Price Forecast by Application (2025-2030) & (USD/mL)
    Table 47. US & Canada Insulin Glargine Sales by Type (2019-2024) & (M mL)
    Table 48. US & Canada Insulin Glargine Sales by Type (2025-2030) & (M mL)
    Table 49. US & Canada Insulin Glargine Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Insulin Glargine Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Insulin Glargine Sales by Application (2019-2024) & (M mL)
    Table 52. US & Canada Insulin Glargine Sales by Application (2025-2030) & (M mL)
    Table 53. US & Canada Insulin Glargine Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Insulin Glargine Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Insulin Glargine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Insulin Glargine Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Insulin Glargine Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Insulin Glargine Sales by Country (2019-2024) & (M mL)
    Table 59. US & Canada Insulin Glargine Sales by Country (2025-2030) & (M mL)
    Table 60. Europe Insulin Glargine Sales by Type (2019-2024) & (M mL)
    Table 61. Europe Insulin Glargine Sales by Type (2025-2030) & (M mL)
    Table 62. Europe Insulin Glargine Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Insulin Glargine Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Insulin Glargine Sales by Application (2019-2024) & (M mL)
    Table 65. Europe Insulin Glargine Sales by Application (2025-2030) & (M mL)
    Table 66. Europe Insulin Glargine Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Insulin Glargine Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Insulin Glargine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Insulin Glargine Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Insulin Glargine Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Insulin Glargine Sales by Country (2019-2024) & (M mL)
    Table 72. Europe Insulin Glargine Sales by Country (2025-2030) & (M mL)
    Table 73. China Insulin Glargine Sales by Type (2019-2024) & (M mL)
    Table 74. China Insulin Glargine Sales by Type (2025-2030) & (M mL)
    Table 75. China Insulin Glargine Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Insulin Glargine Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Insulin Glargine Sales by Application (2019-2024) & (M mL)
    Table 78. China Insulin Glargine Sales by Application (2025-2030) & (M mL)
    Table 79. China Insulin Glargine Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Insulin Glargine Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Insulin Glargine Sales by Type (2019-2024) & (M mL)
    Table 82. Asia Insulin Glargine Sales by Type (2025-2030) & (M mL)
    Table 83. Asia Insulin Glargine Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Insulin Glargine Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Insulin Glargine Sales by Application (2019-2024) & (M mL)
    Table 86. Asia Insulin Glargine Sales by Application (2025-2030) & (M mL)
    Table 87. Asia Insulin Glargine Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Insulin Glargine Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Insulin Glargine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Insulin Glargine Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Insulin Glargine Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Insulin Glargine Sales by Region (2019-2024) & (M mL)
    Table 93. Asia Insulin Glargine Sales by Region (2025-2030) & (M mL)
    Table 94. Middle East, Africa and Latin America Insulin Glargine Sales by Type (2019-2024) & (M mL)
    Table 95. Middle East, Africa and Latin America Insulin Glargine Sales by Type (2025-2030) & (M mL)
    Table 96. Middle East, Africa and Latin America Insulin Glargine Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Insulin Glargine Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Insulin Glargine Sales by Application (2019-2024) & (M mL)
    Table 99. Middle East, Africa and Latin America Insulin Glargine Sales by Application (2025-2030) & (M mL)
    Table 100. Middle East, Africa and Latin America Insulin Glargine Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Insulin Glargine Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Insulin Glargine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Insulin Glargine Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Insulin Glargine Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Insulin Glargine Sales by Country (2019-2024) & (M mL)
    Table 106. Middle East, Africa and Latin America Insulin Glargine Sales by Country (2025-2030) & (M mL)
    Table 107. Sanofi-Aventis Company Information
    Table 108. Sanofi-Aventis Description and Major Businesses
    Table 109. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2019-2024)
    Table 110. Sanofi-Aventis Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Sanofi-Aventis Recent Developments
    Table 112. Ganlee Company Information
    Table 113. Ganlee Description and Major Businesses
    Table 114. Ganlee Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2019-2024)
    Table 115. Ganlee Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Ganlee Recent Developments
    Table 117. Biocon Company Information
    Table 118. Biocon Description and Major Businesses
    Table 119. Biocon Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2019-2024)
    Table 120. Biocon Insulin Glargine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Biocon Recent Developments
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Insulin Glargine Distributors List
    Table 125. Insulin Glargine Customers List
    Table 126. Insulin Glargine Market Trends
    Table 127. Insulin Glargine Market Drivers
    Table 128. Insulin Glargine Market Challenges
    Table 129. Insulin Glargine Market Restraints
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Insulin Glargine Product Picture
    Figure 2. Global Insulin Glargine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Insulin Glargine Market Share by Type in 2023 & 2030
    Figure 4. Single Dose Vial Product Picture
    Figure 5. Pre-filled Syringe Product Picture
    Figure 6. Global Insulin Glargine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Insulin Glargine Market Share by Application in 2023 & 2030
    Figure 8. Treat Type2 Diabetes
    Figure 9. Treat Type1 Diabetes
    Figure 10. Insulin Glargine Report Years Considered
    Figure 11. Global Insulin Glargine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Insulin Glargine Revenue 2019-2030 (US$ Million)
    Figure 13. Global Insulin Glargine Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Insulin Glargine Revenue Market Share by Region (2019-2030)
    Figure 15. Global Insulin Glargine Sales 2019-2030 ((M mL)
    Figure 16. Global Insulin Glargine Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Insulin Glargine Sales YoY (2019-2030) & (M mL)
    Figure 18. US & Canada Insulin Glargine Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Insulin Glargine Sales YoY (2019-2030) & (M mL)
    Figure 20. Europe Insulin Glargine Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Insulin Glargine Sales YoY (2019-2030) & (M mL)
    Figure 22. China Insulin Glargine Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Insulin Glargine Sales YoY (2019-2030) & (M mL)
    Figure 24. Asia (excluding China) Insulin Glargine Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Insulin Glargine Sales YoY (2019-2030) & (M mL)
    Figure 26. Middle East, Africa and Latin America Insulin Glargine Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Insulin Glargine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Insulin Glargine in the World: Market Share by Insulin Glargine Revenue in 2023
    Figure 29. Global Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Insulin Glargine Sales Market Share by Type (2019-2030)
    Figure 31. Global Insulin Glargine Revenue Market Share by Type (2019-2030)
    Figure 32. Global Insulin Glargine Sales Market Share by Application (2019-2030)
    Figure 33. Global Insulin Glargine Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Insulin Glargine Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Insulin Glargine Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Insulin Glargine Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Insulin Glargine Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Insulin Glargine Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Insulin Glargine Sales Share by Country (2019-2030)
    Figure 40. U.S. Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Insulin Glargine Sales Market Share by Type (2019-2030)
    Figure 43. Europe Insulin Glargine Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Insulin Glargine Sales Market Share by Application (2019-2030)
    Figure 45. Europe Insulin Glargine Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Insulin Glargine Revenue Share by Country (2019-2030)
    Figure 47. Europe Insulin Glargine Sales Share by Country (2019-2030)
    Figure 48. Germany Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 49. France Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 53. China Insulin Glargine Sales Market Share by Type (2019-2030)
    Figure 54. China Insulin Glargine Revenue Market Share by Type (2019-2030)
    Figure 55. China Insulin Glargine Sales Market Share by Application (2019-2030)
    Figure 56. China Insulin Glargine Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Insulin Glargine Sales Market Share by Type (2019-2030)
    Figure 58. Asia Insulin Glargine Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Insulin Glargine Sales Market Share by Application (2019-2030)
    Figure 60. Asia Insulin Glargine Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Insulin Glargine Revenue Share by Region (2019-2030)
    Figure 62. Asia Insulin Glargine Sales Share by Region (2019-2030)
    Figure 63. Japan Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 67. India Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Insulin Glargine Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Insulin Glargine Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Insulin Glargine Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Insulin Glargine Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Insulin Glargine Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Insulin Glargine Sales Share by Country (2019-2030)
    Figure 74. Brazil Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Insulin Glargine Revenue (2019-2030) & (US$ Million)
    Figure 79. Insulin Glargine Value Chain
    Figure 80. Insulin Glargine Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions